Jerald C. Sadoff, MD

Dr. Sadoff is President and Chief Executive Officer of Aeras Global TB Vaccine Foundation.

Dr. Sadoff has spent more than three decades developing vaccines for dozens of diseases, from chicken pox to malaria. He came to Aeras from Merck, where he was the Executive Director of Clinical Development of Vaccines. While at Merck, Dr. Sadoff led the efforts to develop and obtain licensure for eight licensed vaccines to prevent: hepatitis A, (VAQTA®); Haemophilus influenza type b (Liquid Pedvax™); 4-degree stable varicella vaccine (Varivax II®); a hepatitis B-Hib (Comvax™); the 6 valent Hep B, Hib, Polio, DTP (Hexavac™); Measles, Mumps, Rubella, Varicella (ProQuad®), and recently Zoster (Zostavax™) and rotavirus (Rotateq®).

Before joining Merck, Dr. Sadoff was Director, Division of Communicable Diseases and Immunology, at the Walter Reed Army Institute of Research, where he worked on vaccines against bacterial, viral and parasitic diseases, including sepsis, gonorrhea, cholera, shigella, dengue, HIV and malaria. He attained the rank of Colonel in the U.S. Medical Corps.

Throughout his career, he has chaired or served on over 20 national and international task forces, initiatives, consulting groups and advisory boards. Currently, he is Chair of the USAID Malaria Vaccine Scientific Consultants Group and Chair of the NIH/NIAID Oversight Task Force for Malaria. He serves on the NIAID AIDS Vaccine Research Working Group and the Scientific Advisory Board of the International AIDS Vaccine Initiative.

Over the last 30 years, he has authored some 300 articles, book chapters, and abstracts. Dr. Sadoff received his BA and MD from the University of Minnesota at Minneapolis.